1. Zhang, H., et al. Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China. Cancer 126, 4023-4031 (2020).
2. Robilotti, E.V., et al. Determinants of COVID-19 disease severity in patients with cancer. Nature Medicine 26, 1218-1223 (2020).
3. Piñana, J.L., et al. Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol 9, 21 (2020).
4. Pagano, L., et al. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol 14, 168 (2021).
5. García-Suárez, J., et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol 13, 133 (2020).
6. Liebers, N., et al. Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients. Blood 139, 142-147 (2022).
7. Zeng, Z., et al. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China. Crit Care 24, 525 (2020).
8. Lee, C.Y., et al. Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies. Cancer Discovery 12, 62-73 (2022).
9. Bange, E.M., et al. CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med 27, 1280-1289 (2021).
10. Broers, A.E.C., et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation. Blood 95, 2240-2245 (2000).
11. Chen, X., et al. Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients. medRxiv, 2020.2003.2003.20030437 (2020).
12. Rivera, D.R., et al. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer Discovery 10, 1514-1527 (2020).
13. Hung, Y.P., et al. Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark? Antibiotics (Basel) 11(2022).
14. Horby, P., et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med 384, 693-704 (2021).
15. Kalil, A.C., et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med 384, 795-807 (2021).
16. Marconi, V.C., et al. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med 9, 1407-1418 (2021).
17. Shi, Z. & Puyo, C.A. N-Acetylcysteine to Combat COVID-19: An Evidence Review. Ther Clin Risk Manag 16, 1047-1055 (2020).
18. Meryk, A., et al. Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice. Antioxidants (Basel) 9(2020).
19. Keays, R., et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Bmj 303, 1026-1029 (1991).
20. Domenighetti, G., Suter, P.M., Schaller, M.D., Ritz, R. & Perret, C. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care 12, 177-182 (1997).
21. Sotelo, N., de los Angeles Durazo, M., Gonzalez, A. & Dhanakotti, N. Early treatment with N-acetylcysteine in children with acute liver failure secondary to hepatitis A. Ann Hepatol 8, 353-358 (2009).
22. Look, M.P., et al. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study. Eur J Clin Invest 28, 389-397 (1998).
23. Buttiron Webber, T., et al. Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. Eur J Cancer 159, 105-112 (2021).
24. Kim, Y.J., Lee, E.S. & Lee, Y.S. High mortality from viral pneumonia in patients with cancer. Infect Dis (Lond) 51, 502-509 (2019).
25. Babady, N.E., et al. Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Real-Time RT-PCR Tests on Oral Rinses and Saliva Samples. J Mol Diagn 23, 3-9 (2021).